FDA Approves New Targeted Pill for Advanced Pancreatic Cancer, Offering Patients a New Treatment Option
WASHINGTON, D.C. — A significant development in pancreatic cancer treatment has emerged in the United States after the U.S. Food...
WASHINGTON, D.C. — A significant development in pancreatic cancer treatment has emerged in the United States after the U.S. Food...
Mainz, Germany, August 29, 2026: BioNTech has stopped a mid-stage clinical trial testing its personalized mRNA cancer immunotherapy in patients...
August 27, 2026 The U.S. Food and Drug Administration has approved Rasonque (daraxonrasib), a new targeted medicine developed by Revolution...
Former U.S. President Joe Biden is facing a worsening battle with prostate cancer, according to new comments from his son,...
The world's cancer burden is entering a critical phase, with new global statistics warning that the number of people diagnosed...
Cancer continues to be one of the world's biggest health challenges, and a new global assessment from the World Health...
Radiotherapy July 2, 2025 – As cancer treatment advances, the focus has increasingly shifted toward therapies that precisely target tumors...